What You Need To Know Ahead of Johnson & Johnson's Earnings Release
By Bullbit Editorial · March 26, 2026
WhatJohnson & Johnson is set to release its Q1 2026 earnings on April 18, 2026.
WhyThe company's vaccine sales and COVID-19 treatment revenue will be closely watched, as well as its performance in key markets like the US and Europe.
SignalAnalysts expect JNJ to report earnings per share of $2.45 on revenue of $24.3B.
TargetThe company's guidance for the full year 2026, which includes a forecast of $102.5B in revenue, will also be a key focus.
RiskJohnson & Johnson's stock has been volatile in recent months, and investors will be watching for any signs of weakness in its pharmaceutical and medical device segments.